Shenyang Xingqi Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 27.46% vs 55.03% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 41.47% vs 320.46% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "683.30",
          "val2": "536.10",
          "chgp": "27.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "225.10",
          "val2": "189.60",
          "chgp": "18.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "1.50",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "206.40",
          "val2": "145.90",
          "chgp": "41.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "329.40%",
          "val2": "303.80%",
          "chgp": "2.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 27.21% vs 32.08% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 105.83% vs 40.88% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,447.30",
          "val2": "1,923.90",
          "chgp": "27.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "919.60",
          "val2": "512.70",
          "chgp": "79.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.80",
          "val2": "6.50",
          "chgp": "-26.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "695.90",
          "val2": "338.10",
          "chgp": "105.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "329.00%",
          "val2": "211.60%",
          "chgp": "11.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

683.30

536.10

27.46%

Operating Profit (PBDIT) excl Other Income

225.10

189.60

18.72%

Interest

0.50

1.50

-66.67%

Exceptional Items

0.00

0.00

Consolidate Net Profit

206.40

145.90

41.47%

Operating Profit Margin (Excl OI)

329.40%

303.80%

2.56%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 27.46% vs 55.03% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 41.47% vs 320.46% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,447.30

1,923.90

27.21%

Operating Profit (PBDIT) excl Other Income

919.60

512.70

79.36%

Interest

4.80

6.50

-26.15%

Exceptional Items

0.00

0.00

Consolidate Net Profit

695.90

338.10

105.83%

Operating Profit Margin (Excl OI)

329.00%

211.60%

11.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 27.21% vs 32.08% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 105.83% vs 40.88% in Dec 2024

All Annual Results